Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OABC
901
DELISTED
OMNIAMERICAN BANCORP INC COM STK (TX)
OABC
| $9.11M | 0.02% |
364,200
+89,800
| +33% | +$2.16M |
|
|
QGENF
902
DELISTED
QIAGEN NV
QGENF
| $9.1M | 0.02% |
372,000
-656,319
| -64% | -$16M |
|
|
ZNGA
903
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $9.07M | 0.02% |
2,826,900
-1,878,700
| -40% | -$6.8M |
|
904
Marvell Technology
MRVL
$199B
| $9.07M | 0.02% |
+633,044
| New | +$9.75M |
|
|
RDS.A
905
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $9.04M | 0.02% |
+117,528
| New | +$8.58M |
|
906
ArcBest
ARCB
$3.28B
| $9.02M | 0.02% |
207,235
-334,100
| -62% | -$13.5M |
|
907
Renasant Corp
RNST
$4B
| $9.01M | 0.02% |
309,836
+53,369
| +21% | +$1.5M |
|
|
HAWK
908
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $8.97M | 0.02% |
317,963
+304,163
| +2,204% | +$7.55M |
|
|
CBPO
909
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $8.9M | 0.02% |
200,100
+69,725
| +53% | +$2.85M |
|
|
HRG
910
DELISTED
HRG Group, Inc.
HRG
| $8.9M | 0.02% |
700,600
+176,712
| +34% | +$2.12M |
|
911
Belden
BDC
$5.36B
| $8.85M | 0.02% |
113,200
+26,999
| +31% | +$1.98M |
|
|
XOXO
912
DELISTED
Xo Group Inc
XOXO
| $8.84M | 0.02% |
723,500
-14,200
| -2% | -$158K |
|
|
MWW
913
DELISTED
Monster Worldwide Inc
MWW
| $8.84M | 0.02% |
1,350,975
-1,245,113
| -48% | -$7.82M |
|
914
Cracker Barrel
CBRL
$1.31B
| $8.83M | 0.02% |
88,700
-166,709
| -65% | -$16.3M |
|
915
SFL Corp
SFL
$1.61B
| $8.81M | 0.02% |
473,732
+96,400
| +26% | +$1.73M |
|
916
Bank of America
BAC
$448B
| $8.8M | 0.02% |
+572,566
| New | +$8.89M |
|
|
DHIL
917
DELISTED
Diamond Hill
DHIL
| $8.76M | 0.02% |
68,575
+5,064
| +8% | +$624K |
|
|
JBTM
918
JBT Marel
JBTM
$6.1B
| $8.75M | 0.02% |
282,300
+71,796
| +34% | +$2.13M |
|
919
STAG Industrial
STAG
$7.12B
| $8.74M | 0.02% |
363,900
+118,134
| +48% | +$2.83M |
|
|
LDL
920
DELISTED
Lydall, Inc.
LDL
| $8.71M | 0.02% |
318,200
-28,300
| -8% | -$727K |
|
|
NTP
921
DELISTED
Nam Tai Property Inc.
NTP
| $8.7M | 0.02% |
1,153,200
+156,100
| +16% | +$1.13M |
|
|
KONA
922
DELISTED
Kona Grill, Inc.
KONA
| $8.69M | 0.02% |
447,859
-5,268
| -1% | -$109K |
|
|
BKW
923
DELISTED
BURGER KING WORLDWIDE
BKW
| $8.69M | 0.02% |
319,100
+93,281
| +41% | +$2.42M |
|
924
RLJ Lodging Trust
RLJ
$1.67B
| $8.67M | 0.02% |
300,200
+86,300
| +40% | +$2.34M |
|
925
Motorcar Parts of America
MPAA
$235M
| $8.67M | 0.02% |
355,900
+130,700
| +58% | +$3.33M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.